Researchers have identified a rare type of disease-causing mutation, called a multi-exon deletion in the COL5A1 gene, in a girl…
Articles by Marisa Wexler, MS
Signs of dysfunction in small nerve fibers, the nerve cells mainly responsible for detecting sensations like pain, are found in…
Aytu BioPharma has launched a Phase 3 trial, called PREVEnt, to evaluate its experimental oral treatment AR101 (enzastaurin) in people…
Imbalances among sensory signals may contribute to the chronic pain experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), according…
The Ehlers-Danlos Society has announced $400,000 in funding for a new research project that seeks to shed light on…
Gamers Outreach and Xbox are working together to promote a documentary that showcases how gaming can help to forge…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Edsivo (celiprolol) has been granted a breakthrough therapy designation for COL3A1-positive vascular Ehlers-Danlos syndrome (vEDS) by the U.S.
Following a meeting with the U.S. Food and Drug Administration (FDA), Acer Therapeutics is planning to launch a potentially…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…